The Role of Antioxidants in Preventing Chronic Kidney Disease Progression: Mechanisms and Clinical Implications
DOI:
https://doi.org/10.70749/ijbr.v3i2.753Keywords:
Chronic Kidney Disease (CKD), Oxidative Stress, Antioxidant Supplementation, Smoking, Hypertension, Dietary habits, Kidney Function, ComorbiditiesAbstract
This study aims to investigate the determinants of the progression of Chronic Kidney Disease (CKD) and the role of antioxidant supplementation in managing oxidative stress and kidney function. The research used a cross-sectional study with 120 participants, considering variables such as age, gender, smoking, family history, diet, alcohol consumption, education, and occupation. Key findings from the analysis were that age was a significant contributing factor to CKD progression, with older individuals having greater likelihood of developing advanced disease stages. Males, particularly those with hypertension, had increased prevalence of kidney damage. Smoking was also found to accelerate CKD progression, with intake of a diet rich in fruits and vegetables being associated with high antioxidant use. The intervention group, supplemented with antioxidants, evidenced remarkable reductions in indicators of oxidative stress as well as improvement of kidney function compared to existing levels, as shown by statistical comparison through Paired t-tests and Wilcoxon Signed-Rank Tests (p < 0.05). The control group, on the other hand, experienced no similar significant alterations. In addition, a multivariable regression model proved the impact of age, baseline kidney function, and comorbid illness on CKD outcomes with poorer outcomes in older patients and reduced baseline eGFR. The findings suggest that lifestyle modifications such as smoking abstinence and diet change, and antioxidant supplementation may have a significant role in CKD progression and oxidative stress and are potential targets for clinical intervention. This study highlights key determinants influencing Chronic Kidney Disease (CKD) progression, emphasizing modifiable risk factors like smoking, diet, alcohol use, and physical activity. Findings support antioxidant supplementation and lifestyle modifications as crucial strategies for slowing CKD progression and improving renal health outcomes.
Downloads
References
Mohany, M., Ahmed, M. M., & Al-Rejaie, S. S. (2021). Molecular mechanistic pathways targeted by natural antioxidants in the prevention and treatment of chronic kidney disease. Antioxidants, 11(1), 15. https://doi.org/10.3390/antiox11010015
Casanova, A. G., López-Hernández, F. J., Vicente-Vicente, L., & Morales, A. I. (2021). Are antioxidants useful in preventing the progression of chronic kidney disease? Antioxidants, 10(11), 1669. https://doi.org/10.3390/antiox10111669
Dennis, J., & Witting, P. (2017). Protective role for antioxidants in acute kidney disease. Nutrients, 9(7), 718. https://doi.org/10.3390/nu9070718
Tylicki, L., Rutkowski, B., & Hörl, W. H. (2003). Antioxidants: A possible role in kidney protection. Kidney and Blood Pressure Research, 26(5-6), 303-314. https://doi.org/10.1159/000073936
Sun, Y., Jin, D., Zhang, Z., Zhang, Y., Zhang, Y., Kang, X., Jiang, L., Tong, X., & Lian, F. (2023). Effects of antioxidants on diabetic kidney diseases: Mechanistic interpretations and clinical assessment. Chinese Medicine, 18(1). https://doi.org/10.1186/s13020-022-00700-w
Verma, S., Singh, P., Khurana, S., Ganguly, N. K., Kukreti, R., Saso, L., Rana, D. S., Taneja, V., & Bhargava, V. (2021). Implications of oxidative stress in chronic kidney disease: A review on current concepts and therapies. Kidney Research and Clinical Practice, 40(2), 183-193. https://doi.org/10.23876/j.krcp.20.163
Podkowińska, A., & Formanowicz, D. (2020). Chronic kidney disease as oxidative stress- and inflammatory-mediated cardiovascular disease. Antioxidants, 9(8), 752. https://doi.org/10.3390/antiox9080752
Rapa, S. F., Di Iorio, B. R., Campiglia, P., Heidland, A., & Marzocco, S. (2019). Inflammation and oxidative stress in chronic kidney disease—Potential therapeutic role of minerals, vitamins and plant-derived metabolites. International Journal of Molecular Sciences, 21(1), 263. https://doi.org/10.3390/ijms21010263
Daenen, K., Andries, A., Mekahli, D., Van Schepdael, A., Jouret, F., & Bammens, B. (2018). Oxidative stress in chronic kidney disease. Pediatric Nephrology, 34(6), 975-991. https://doi.org/10.1007/s00467-018-4005-4
Lee, O. Y., Wong, A. N., Ho, C. Y., Tse, K. W., Chan, A. Z., Leung, G. P., Kwan, Y. W., & Yeung, M. H. (2024). Potentials of natural antioxidants in reducing inflammation and oxidative stress in chronic kidney disease. Antioxidants, 13(6), 751. https://doi.org/10.3390/antiox13060751
Di Vincenzo, A., Tana, C., El Hadi, H., Pagano, C., Vettor, R., & Rossato, M. (2019). Antioxidant, anti-inflammatory, and metabolic properties of tocopherols and Tocotrienols: Clinical implications for vitamin E supplementation in diabetic kidney disease. International Journal of Molecular Sciences, 20(20), 5101. https://doi.org/10.3390/ijms20205101
Roumeliotis, S., Roumeliotis, A., Dounousi, E., Eleftheriadis, T., & Liakopoulos, V. (2019). Dietary antioxidant supplements and uric acid in chronic kidney disease: A review. Nutrients, 11(8), 1911. https://doi.org/10.3390/nu11081911
Al-Waili, N., Al-Waili, H., Al-Waili, T., & Salom, K. (2017). Natural antioxidants in the treatment and prevention of diabetic nephropathy; a potential approach that warrants clinical trials. Redox Report, 22(3), 99-118. https://doi.org/10.1080/13510002.2017.1297885
Xie, Y., Liu, F., Zhang, X., Jin, Y., Li, Q., Shen, H., Fu, H., & Mao, J. (2022). Benefits and risks of essential trace elements in chronic kidney disease: A narrative review. Annals of Translational Medicine, 10(24), 1400-1400. https://doi.org/10.21037/atm-22-5969
Shah, S. V., Baliga, R., Rajapurkar, M., & Fonseca, V. A. (2007). Oxidants in chronic kidney disease. Journal of the American Society of Nephrology, 18(1), 16-28. https://doi.org/10.1681/asn.2006050500
Dehkordi, A. H., Ghaderi, M., Mardani, H., Joneghani, A. S., & Dehkordi, A. H. (2022). Antioxidants and their role in the prevention and treatment of chronic kidney disease (CKD), perspective of complementary nursing and medicine: A review. Przeglad Epidemiologiczny, 76(1), 51-57. https://doi.org/10.32394/pe.76.06
WILLCOX, J. K., ASH, S. L., & CATIGNANI, G. L. (2004). Antioxidants and prevention of chronic disease. Critical Reviews in Food Science and Nutrition, 44(4), 275-295. https://doi.org/10.1080/10408690490468489
Cachofeiro, V., Goicochea, M., De Vinuesa, S. G., Oubiña, P., Lahera, V., & Luño, J. (2008). Oxidative stress and inflammation, a link between chronic kidney disease and cardiovascular disease: New strategies to prevent cardiovascular risk in chronic kidney disease. Kidney International, 74, S4-S9. https://doi.org/10.1038/ki.2008.516
Sung, C. C., Hsu, Y. C., Chen, C. C., Lin, Y. F., & Wu, C. C. (2013). Oxidative stress and nucleic acid oxidation in patients with chronic kidney disease. Oxidative medicine and cellular longevity, 2013(1), 301982. https://doi.org/10.1155/2013/301982
Choi, B., Kang, K., & Kwak, M. (2014). Effect of redox modulating NRF2 activators on chronic kidney disease. Molecules, 19(8), 12727-12759. https://doi.org/10.3390/molecules190812727
Mihai, S., Codrici, E., Popescu, I. D., Enciu, A., Albulescu, L., Necula, L. G., Mambet, C., Anton, G., & Tanase, C. (2018). Inflammation-related mechanisms in chronic kidney disease prediction, progression, and outcome. Journal of Immunology Research, 2018, 1-16. https://doi.org/10.1155/2018/2180373
Duni, A., Liakopoulos, V., Rapsomanikis, K., & Dounousi, E. (2017). Chronic kidney disease and disproportionally increased cardiovascular damage: Does oxidative stress explain the burden? Oxidative Medicine and Cellular Longevity, 2017(1). https://doi.org/10.1155/2017/9036450
AMIN, R., DEY, B. K., ALAM, F., SHARIFI-RAD, J., & CALINA, D. (2024). Antioxidant strategies and oxidative stress dynamics in chronic kidney disease: An integrative insight. Minerva Biotechnology and Biomolecular Research, 36(3). https://doi.org/10.23736/s2724-542x.24.03117-1
Kao, M. P., Ang, D. S., Pall, A., & Struthers, A. D. (2009). Oxidative stress in renal dysfunction: Mechanisms, clinical sequelae and therapeutic options. Journal of Human Hypertension, 24(1), 1-8. https://doi.org/10.1038/jhh.2009.70
Yuan, Q., Tang, B., & Zhang, C. (2022). Signaling pathways of chronic kidney diseases, implications for therapeutics. Signal Transduction and Targeted Therapy, 7(1). https://doi.org/10.1038/s41392-022-01036-5
Wang, N., & Zhang, C. (2024). Oxidative stress: A culprit in the progression of diabetic kidney disease. Antioxidants, 13(4), 455. https://doi.org/10.3390/antiox13040455
Tirichen, H., Yaigoub, H., Xu, W., Wu, C., Li, R., & Li, Y. (2021). Mitochondrial reactive oxygen species and their contribution in chronic kidney disease progression through oxidative stress. Frontiers in Physiology, 12. https://doi.org/10.3389/fphys.2021.627837
Signorini, L., Granata, S., Lupo, A., & Zaza, G. (2017). Naturally occurring compounds: New potential weapons against oxidative stress in chronic kidney disease. International Journal of Molecular Sciences, 18(7), 1481. https://doi.org/10.3390/ijms18071481
García-Sánchez, A., Miranda-Díaz, A. G., & Cardona-Muñoz, E. G. (2020). The role of oxidative stress in Physiopathology and pharmacological treatment with pro- and antioxidant properties in chronic diseases. Oxidative Medicine and Cellular Longevity, 2020, 1-16. https://doi.org/10.1155/2020/2082145
Ratliff, B. B., Abdulmahdi, W., Pawar, R., & Wolin, M. S. (2016). Oxidant mechanisms in renal injury and disease. Antioxidants & Redox Signaling, 25(3), 119-146. https://doi.org/10.1089/ars.2016.6665
Zheng, C., Hou, Y., Liao, M., Tsai, K., Hu, W., Yeh, C., & Lu, K. (2024). Potential role of molecular hydrogen therapy on oxidative stress and redox signaling in chronic kidney disease. Biomedicine & Pharmacotherapy, 176, 116802. https://doi.org/10.1016/j.biopha.2024.116802
Fontecha-Barriuso, M., Lopez-Diaz, A. M., Guerrero-Mauvecin, J., Miguel, V., Ramos, A. M., Sanchez-Niño, M. D., ... & Sanz, A. B. (2022). Tubular mitochondrial dysfunction, oxidative stress, and progression of chronic kidney disease. Antioxidants, 11(7), 1356. https://doi.org/10.3390/antiox11071356
Kishi, S., Nagasu, H., Kidokoro, K., & Kashihara, N. (2023). Oxidative stress and the role of redox signalling in chronic kidney disease. Nature Reviews Nephrology, 20(2), 101-119. https://doi.org/10.1038/s41581-023-00775-0
Small, D. M., & Gobe, G. C. (2013). Oxidative stress and antioxidant therapy in chronic kidney and cardiovascular disease (Vol. 10). chapter.
Impellizzeri, D., Esposito, E., Attley, J., & Cuzzocrea, S. (2014). Targeting inflammation: New therapeutic approaches in chronic kidney disease (CKD). Pharmacological Research, 81, 91-102. https://doi.org/10.1016/j.phrs.2014.02.007
Chang, J., Yan, J., Li, X., Liu, N., Zheng, R., & Zhong, Y. (2021). Update on the mechanisms of tubular cell injury in diabetic kidney disease. Frontiers in Medicine, 8. https://doi.org/10.3389/fmed.2021.661076
Chen, Y., Kanwar, Y. S., Chen, X., & Zhan, M. (2024). Aging and diabetic kidney disease: Emerging PathogeneticMechanisms and clinical implications. Current Medicinal Chemistry, 31(6), 697-725. https://doi.org/10.2174/0929867330666230621112215
Ambrosino, P., Bachetti, T., D’Anna, S. E., Galloway, B., Bianco, A., D’Agnano, V., Papa, A., Motta, A., Perrotta, F., & Maniscalco, M. (2022). Mechanisms and clinical implications of endothelial dysfunction in arterial hypertension. Journal of Cardiovascular Development and Disease, 9(5), 136. https://doi.org/10.3390/jcdd9050136
Duni, A., Liakopoulos, V., Roumeliotis, S., Peschos, D., & Dounousi, E. (2019). Oxidative stress in the pathogenesis and evolution of chronic kidney disease: Untangling Ariadne’s thread. International Journal of Molecular Sciences, 20(15), 3711. https://doi.org/10.3390/ijms20153711
Su, Z., Klein, J. D., Du, J., Franch, H. A., Zhang, L., Hassounah, F., Hudson, M. B., & Wang, X. H. (2017). Chronic kidney disease induces autophagy leading to dysfunction of mitochondria in skeletal muscle. American Journal of Physiology-Renal Physiology, 312(6), F1128-F1140. https://doi.org/10.1152/ajprenal.00600.2016
Nuhu, F., & Bhandari, S. (2018). Oxidative stress and cardiovascular complications in chronic kidney disease, the impact of anaemia. Pharmaceuticals, 11(4), 103. https://doi.org/10.3390/ph11040103
Gallo, G., Volpe, M., & Savoia, C. (2022). Endothelial dysfunction in hypertension: Current concepts and clinical implications. Frontiers in Medicine, 8. https://doi.org/10.3389/fmed.2021.798958
Eirin, A., Lerman, A., & Lerman, L. O. (2016). The emerging role of mitochondrial targeting in kidney disease. Handbook of Experimental Pharmacology, 229-250. https://doi.org/10.1007/164_2016_6
Korsmo, H. W., Ekperikpe, U. S., & Daehn, I. S. (2024). Emerging roles of xanthine Oxidoreductase in chronic kidney disease. Antioxidants, 13(6), 712. https://doi.org/10.3390/antiox13060712
Bao, N., Chen, F., & Dai, D. (2020). The regulation of host intestinal microbiota by polyphenols in the development and prevention of chronic kidney disease. Frontiers in Immunology, 10. https://doi.org/10.3389/fimmu.2019.02981
Shang, J., Liu, H., Zheng, Y., & Zhang, Z. (2023). Role of oxidative stress in the relationship between periodontitis and systemic diseases. Frontiers in Physiology, 14. https://doi.org/10.3389/fphys.2023.1210449
Ranasinghe, P., Pigera, S., Galappatthy, P., Katulanda, P., & Constantine, G. R. (2015). Zinc and diabetes mellitus: Understanding molecular mechanisms and clinical implications. DARU Journal of Pharmaceutical Sciences, 23(1). https://doi.org/10.1186/s40199-015-0127-4
Kitada, M., Xu, J., Ogura, Y., Monno, I., & Koya, D. (2020). Manganese superoxide Dismutase dysfunction and the pathogenesis of kidney disease. Frontiers in Physiology, 11. https://doi.org/10.3389/fphys.2020.00755
Kaur, J., Young, B., & Fadel, P. (2017). Sympathetic overactivity in chronic kidney disease: Consequences and mechanisms. International Journal of Molecular Sciences, 18(8), 1682. https://doi.org/10.3390/ijms18081682
Gembillo, G., Visconti, L., Giuffrida, A. E., Labbozzetta, V., Peritore, L., Lipari, A., Calabrese, V., Piccoli, G. B., Torreggiani, M., Siligato, R., & Santoro, D. (2022). Role of zinc in diabetic kidney disease. Nutrients, 14(7), 1353. https://doi.org/10.3390/nu14071353
Kielstein, J. T., Pontremoli, R., & Burnier, M. (2020). Management of hyperuricemia in patients with chronic kidney disease: A focus on renal protection. Current Hypertension Reports, 22(12). https://doi.org/10.1007/s11906-020-01116-3
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Indus Journal of Bioscience Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
